Franco J. Vizeacoumar
Regina, SK S4W0G3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges.
Journal: Current oncology (Toronto, Ont.)
Published: June 20, 2026
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Journal: Signal transduction and targeted therapy
Published: August 13, 2025
Unraveling bladder cancer-related circRNA biomarkers: a hybrid model combining deep learning and statistics.
Journal: Health information science and systems
Published: May 21, 2025
Initial leukemic epigenomic state determines hypomethylating agent response.
Journal: Nature communications
Published: April 29, 2025
The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells.
Journal: Cancer cell international
Published: February 28, 2025
Metabolic Effects of the Cancer Metastasis Modulator MEMO1.
Journal: Metabolites
Published: February 28, 2025
Cancer Cell's Achilles Heels: Considerations for Design of Anti-Cancer Drug Combinations.
Journal: International journal of molecular sciences
Published: December 02, 2024
MDS/AML-associated DDX41 helicase facilitates homologous recombination repair by potentially resolving R-loops.
Journal: Nucleic acids research
Published: October 31, 2024
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.
Journal: Oncogene
Published: October 22, 2024
Differential effects on tumor progression by APOBEC3A, APOBEC3B, and APOBEC3H Haplotype I in a breast cancer mouse xenograft model.
Journal: Frontiers in genetics
Published: April 29, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.
Journal: Gynecologic oncology
Published: March 28, 2024
Last Updated: 09/26/2026